Symbols / SKIN The Beauty Health Company
SKIN Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Market Cap | 114.89M | Enterprise Value | — | Income | — | Sales | — | Book/sh | — | Cash/sh | — |
| Dividend Yield | — | Payout | — | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | — | P/C | — | EV/EBITDA | — | EV/Sales | — |
| Quick Ratio | — | Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | — | ROE | — | ROIC | — |
| Gross Margin | — | Oper. Margin | — | Profit Margin | — | Shs Outstand | — | Shs Float | — | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | — | 52W Low | — | Beta | — | Avg Volume | — |
| Volume | — | Target Price | — | Recom | — | Prev Close | — | Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- Same SKIN ticker, new name: Beauty Health shifts to SkinHealth Systems - Stock Titan Wed, 22 Apr 2026 12
- SKIN (The Beauty Health Company) reports Q4 2025 wider-than-expected loss and 10% YoY revenue drop, shares fall 2.02%. - Crowd Sentiment Stocks - Xã Thanh Hà Wed, 22 Apr 2026 21
- Why BeautyHealth (SKIN) Stock Is Nosediving - Yahoo Finance ue, 23 Sep 2025 07
- Three new directors join SkinHealth board ahead of two departures - Stock Titan Wed, 22 Apr 2026 20
- Replimune Stock Tumbles After FDA Rejects Skin Cancer Therapy for Second Time - Barron's Fri, 10 Apr 2026 07
- STRATA Skin Sciences stock plunges after Nasdaq delisting notice - Investing.com hu, 12 Feb 2026 08
- Nu Skin (NUS) Stock: Suitable for Investors? (+3.27%) 2026-04-18 - Social Buy Zones - Cổng thông tin điện tử Tỉnh Sơn La Sat, 18 Apr 2026 12
- SkinHealth Systems (SKIN) director Edward Beattie files initial Form 3 - Stock Titan Wed, 22 Apr 2026 20
- 3 Reasons SKIN is Risky and 1 Stock to Buy Instead - Yahoo Finance Sun, 31 Aug 2025 07
- Earnings call transcript: Nu Skin misses Q4 2025 earnings forecast, stock rises - Investing.com hu, 12 Feb 2026 08
- Some clinics saw 50%+ higher consult conversions with this skin AI - Stock Titan Wed, 22 Apr 2026 12
- Why BeautyHealth (SKIN) Shares Are Falling Today - Yahoo Finance Mon, 03 Nov 2025 08
- Nu Skin Enterprises (NYSE:NUS) shareholders have endured a 77% loss from investing in the stock five years ago - Yahoo Finance ue, 14 Oct 2025 07
- Millennium entities hold 6.51M SKIN shares (5.1%) — The Beauty Health (SKIN) - Stock Titan Mon, 20 Apr 2026 21
- Don't Overlook Beauty Health (SKIN) International Revenue Trends While Assessing the Stock - Yahoo Finance ue, 17 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
300.79
-10.02%
|
334.29
-16.00%
|
397.99
+8.78%
|
365.88
|
| Operating Revenue |
|
300.79
-10.02%
|
334.29
-16.00%
|
397.99
+8.78%
|
365.88
|
| Cost Of Revenue |
|
104.43
-31.30%
|
152.00
-37.42%
|
242.88
+107.42%
|
117.10
|
| Reconciled Cost Of Revenue |
|
104.43
-31.30%
|
152.00
-37.42%
|
242.88
+107.42%
|
117.10
|
| Gross Profit |
|
196.36
+7.72%
|
182.30
+17.52%
|
155.11
-37.65%
|
248.78
|
| Operating Expense |
|
217.17
-13.16%
|
250.07
-12.57%
|
286.03
+4.15%
|
274.62
|
| Research And Development |
|
5.63
-10.61%
|
6.30
-37.68%
|
10.10
+19.64%
|
8.44
|
| Selling General And Administration |
|
211.54
-13.22%
|
243.77
-11.65%
|
275.93
+3.66%
|
266.18
|
| Selling And Marketing Expense |
|
93.59
-20.89%
|
118.31
-18.12%
|
144.50
-9.73%
|
160.08
|
| General And Administrative Expense |
|
117.95
-5.99%
|
125.46
-4.54%
|
131.43
+23.88%
|
106.10
|
| Other Gand A |
|
117.95
-5.99%
|
125.46
-4.54%
|
131.43
+23.88%
|
106.10
|
| Total Expenses |
|
321.59
-20.02%
|
402.07
-23.98%
|
528.91
+35.02%
|
391.72
|
| Operating Income |
|
-20.80
+69.31%
|
-67.77
+48.23%
|
-130.92
-406.63%
|
-25.84
|
| Total Operating Income As Reported |
|
-20.80
+69.31%
|
-67.77
+48.23%
|
-130.92
-406.63%
|
-25.84
|
| EBITDA |
|
38.74
+166.38%
|
14.54
+127.15%
|
-53.56
-165.64%
|
81.60
|
| Normalized EBITDA |
|
32.43
+101.27%
|
16.11
+123.74%
|
-67.87
-1589.34%
|
4.56
|
| Reconciled Depreciation |
|
25.35
-24.74%
|
33.68
-2.87%
|
34.67
+51.60%
|
22.87
|
| EBIT |
|
13.39
+169.96%
|
-19.14
+78.31%
|
-88.24
-250.24%
|
58.73
|
| Total Unusual Items |
|
6.31
+501.40%
|
-1.57
-110.98%
|
14.30
-81.43%
|
77.05
|
| Total Unusual Items Excluding Goodwill |
|
6.31
+501.40%
|
-1.57
-110.98%
|
14.30
-81.43%
|
77.05
|
| Net Income |
|
-9.52
+67.29%
|
-29.10
+70.94%
|
-100.12
-326.38%
|
44.22
|
| Pretax Income |
|
-5.94
+79.91%
|
-29.55
+71.00%
|
-101.89
-324.73%
|
45.34
|
| Net Non Operating Interest Income Expense |
|
-10.37
-266.43%
|
6.23
-34.57%
|
9.52
+325.85%
|
-4.22
|
| Interest Expense Non Operating |
|
19.33
+85.61%
|
10.41
-23.72%
|
13.65
+1.92%
|
13.39
|
| Net Interest Income |
|
-10.37
-266.43%
|
6.23
-34.57%
|
9.52
+325.85%
|
-4.22
|
| Interest Expense |
|
19.33
+85.61%
|
10.41
-23.72%
|
13.65
+1.92%
|
13.39
|
| Interest Income Non Operating |
|
8.95
-46.20%
|
16.64
-28.18%
|
23.17
+152.57%
|
9.18
|
| Interest Income |
|
8.95
-46.20%
|
16.64
-28.18%
|
23.17
+152.57%
|
9.18
|
| Other Income Expense |
|
25.24
-21.11%
|
31.99
+64.03%
|
19.50
-74.13%
|
75.40
|
| Other Non Operating Income Expenses |
|
18.93
-43.60%
|
33.56
+545.44%
|
5.20
+415.15%
|
-1.65
|
| Gain On Sale Of Security |
|
6.31
+501.40%
|
-1.57
-110.98%
|
14.30
-81.43%
|
77.05
|
| Tax Provision |
|
3.58
+892.26%
|
-0.45
+74.51%
|
-1.77
-259.01%
|
1.11
|
| Tax Rate For Calcs |
|
0.00
+1300.00%
|
0.00
-13.80%
|
0.00
-27.50%
|
0.00
|
| Tax Effect Of Unusual Items |
|
1.32
+5719.61%
|
-0.02
-109.47%
|
0.25
-86.54%
|
1.85
|
| Net Income Including Noncontrolling Interests |
|
-9.52
+67.29%
|
-29.10
+70.94%
|
-100.12
-326.38%
|
44.22
|
| Net Income From Continuing Operation Net Minority Interest |
|
-9.52
+67.29%
|
-29.10
+70.94%
|
-100.12
-326.38%
|
44.22
|
| Net Income From Continuing And Discontinued Operation |
|
-9.52
+67.29%
|
-29.10
+70.94%
|
-100.12
-326.38%
|
44.22
|
| Net Income Continuous Operations |
|
-9.52
+67.29%
|
-29.10
+70.94%
|
-100.12
-326.38%
|
44.22
|
| Normalized Income |
|
-14.50
+47.37%
|
-27.55
+75.87%
|
-114.17
-268.60%
|
-30.97
|
| Net Income Common Stockholders |
|
-9.52
+67.29%
|
-29.10
+70.94%
|
-100.12
-326.38%
|
44.22
|
| Diluted EPS |
|
-0.16
+30.43%
|
-0.23
+69.74%
|
-0.76
-430.43%
|
0.23
|
| Basic EPS |
|
-0.08
+65.22%
|
-0.23
+69.74%
|
-0.76
-353.33%
|
0.30
|
| Basic Average Shares |
|
126.38
+2.06%
|
123.83
-5.96%
|
131.68
-10.76%
|
147.55
|
| Diluted Average Shares |
|
135.80
+9.67%
|
123.83
-5.96%
|
131.68
-11.33%
|
148.51
|
| Diluted NI Availto Com Stockholders |
|
-22.11
+57.29%
|
-51.77
+48.29%
|
-100.12
-193.43%
|
-34.12
|
| Average Dilution Earnings |
|
-12.59
+44.47%
|
-22.67
|
0.00
+100.00%
|
-78.34
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
929.11
|
| Current Assets |
|
698.25
|
| Cash Cash Equivalents And Short Term Investments |
|
523.02
|
| Cash And Cash Equivalents |
|
523.02
|
| Receivables |
|
55.03
|
| Accounts Receivable |
|
54.70
|
| Gross Accounts Receivable |
|
61.30
|
| Allowance For Doubtful Accounts Receivable |
|
-6.60
|
| Taxes Receivable |
|
0.33
|
| Inventory |
|
91.32
|
| Raw Materials |
|
24.41
|
| Finished Goods |
|
66.92
|
| Prepaid Assets |
|
—
|
| Other Current Assets |
|
28.88
|
| Total Non Current Assets |
|
230.86
|
| Net PPE |
|
26.35
|
| Gross PPE |
|
46.30
|
| Accumulated Depreciation |
|
-19.95
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
20.22
|
| Construction In Progress |
|
0.75
|
| Other Properties |
|
13.01
|
| Leases |
|
12.32
|
| Goodwill And Other Intangible Assets |
|
187.94
|
| Goodwill |
|
125.82
|
| Other Intangible Assets |
|
62.12
|
| Non Current Deferred Assets |
|
0.53
|
| Non Current Deferred Taxes Assets |
|
0.53
|
| Other Non Current Assets |
|
16.04
|
| Total Liabilities Net Minority Interest |
|
869.72
|
| Current Liabilities |
|
115.01
|
| Payables And Accrued Expenses |
|
84.95
|
| Payables |
|
62.96
|
| Accounts Payable |
|
44.77
|
| Other Payable |
|
—
|
| Current Accrued Expenses |
|
21.99
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
4.00
|
| Total Tax Payable |
|
18.19
|
| Income Tax Payable |
|
2.76
|
| Current Debt And Capital Lease Obligation |
|
4.60
|
| Current Debt |
|
—
|
| Other Current Borrowings |
|
—
|
| Current Capital Lease Obligation |
|
4.60
|
| Current Deferred Liabilities |
|
0.45
|
| Current Deferred Revenue |
|
0.45
|
| Total Non Current Liabilities Net Minority Interest |
|
754.72
|
| Long Term Debt And Capital Lease Obligation |
|
747.69
|
| Long Term Debt |
|
738.37
|
| Long Term Capital Lease Obligation |
|
9.32
|
| Non Current Deferred Liabilities |
|
0.70
|
| Non Current Deferred Taxes Liabilities |
|
0.70
|
| Other Non Current Liabilities |
|
2.77
|
| Stockholders Equity |
|
59.39
|
| Common Stock Equity |
|
59.39
|
| Capital Stock |
|
0.01
|
| Common Stock |
|
0.01
|
| Preferred Stock |
|
—
|
| Share Issued |
|
122.90
|
| Ordinary Shares Number |
|
122.90
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
541.28
|
| Retained Earnings |
|
-478.87
|
| Gains Losses Not Affecting Retained Earnings |
|
-3.04
|
| Other Equity Adjustments |
|
-3.04
|
| Total Equity Gross Minority Interest |
|
59.39
|
| Total Capitalization |
|
797.76
|
| Working Capital |
|
583.24
|
| Invested Capital |
|
797.76
|
| Total Debt |
|
752.29
|
| Net Debt |
|
215.35
|
| Capital Lease Obligations |
|
13.92
|
| Net Tangible Assets |
|
-128.55
|
| Tangible Book Value |
|
-128.55
|
| Current Provisions |
|
21.01
|
| Derivative Product Liabilities |
|
3.56
|
| Interest Payable |
|
2.34
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
37.48
+132.34%
|
16.13
-25.82%
|
21.75
+120.40%
|
-106.60
|
| Cash Flow From Continuing Operating Activities |
|
37.48
+132.34%
|
16.13
-25.82%
|
21.75
+120.40%
|
-106.60
|
| Net Income From Continuing Operations |
|
-9.52
+67.29%
|
-29.10
+70.94%
|
-100.12
-326.38%
|
44.22
|
| Depreciation Amortization Depletion |
|
25.35
-24.74%
|
33.68
-2.87%
|
34.67
+51.60%
|
22.87
|
| Depreciation |
|
3.85
-61.29%
|
9.94
-12.28%
|
11.33
+58.18%
|
7.16
|
| Amortization Cash Flow |
|
21.50
-9.43%
|
23.74
+1.70%
|
23.34
+48.60%
|
15.71
|
| Depreciation And Amortization |
|
25.35
-24.74%
|
33.68
-2.87%
|
34.67
+51.60%
|
22.87
|
| Amortization Of Intangibles |
|
21.50
-9.43%
|
23.74
+1.70%
|
23.34
+48.60%
|
15.71
|
| Other Non Cash Items |
|
-14.56
-3.18%
|
-14.11
-224.92%
|
11.30
-31.29%
|
16.44
|
| Stock Based Compensation |
|
14.82
-44.47%
|
26.70
+18.42%
|
22.54
-20.88%
|
28.50
|
| Provisionand Write Offof Assets |
|
2.07
-59.74%
|
5.13
-0.37%
|
5.15
+217.69%
|
1.62
|
| Asset Impairment Charge |
|
7.22
-74.26%
|
28.04
-25.90%
|
37.84
+635.61%
|
5.14
|
| Deferred Tax |
|
2.22
+159.20%
|
-3.75
-247.36%
|
-1.08
+39.62%
|
-1.79
|
| Deferred Income Tax |
|
2.22
+159.20%
|
-3.75
-247.36%
|
-1.08
+39.62%
|
-1.79
|
| Operating Gains Losses |
|
-0.49
+84.12%
|
-3.07
+74.27%
|
-11.92
+84.79%
|
-78.34
|
| Gain Loss On Investment Securities |
|
-0.49
+84.12%
|
-3.07
+74.27%
|
-11.92
+84.79%
|
-78.34
|
| Net Foreign Currency Exchange Gain Loss |
|
—
|
—
|
—
|
2.41
|
| Gain Loss On Sale Of PPE |
|
—
|
—
|
—
|
5.24
|
| Change In Working Capital |
|
10.37
+137.87%
|
-27.39
-217.28%
|
23.36
+116.08%
|
-145.27
|
| Change In Receivables |
|
5.16
-75.19%
|
20.80
+25.93%
|
16.52
+151.58%
|
-32.02
|
| Changes In Account Receivables |
|
5.16
-75.19%
|
20.80
+25.93%
|
16.52
+151.58%
|
-32.02
|
| Change In Inventory |
|
15.79
+250.40%
|
-10.50
+53.57%
|
-22.62
+73.19%
|
-84.36
|
| Change In Prepaid Assets |
|
3.42
-77.89%
|
15.48
+322.69%
|
-6.95
+49.80%
|
-13.85
|
| Change In Payables And Accrued Expense |
|
-7.18
+83.60%
|
-43.78
-199.49%
|
44.00
+1589.54%
|
-2.95
|
| Change In Accrued Expense |
|
—
|
—
|
26.94
+902.38%
|
-3.36
|
| Change In Payable |
|
—
|
—
|
17.07
+845.95%
|
1.80
|
| Change In Account Payable |
|
—
|
—
|
15.78
+882.75%
|
1.61
|
| Change In Other Working Capital |
|
-6.83
+27.39%
|
-9.40
-23.73%
|
-7.60
+37.10%
|
-12.08
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
-8.04
|
| Change In Other Current Liabilities |
|
—
|
—
|
—
|
-4.03
|
| Investing Cash Flow |
|
-5.16
+24.01%
|
-6.79
+78.44%
|
-31.51
-66.98%
|
-18.87
|
| Cash Flow From Continuing Investing Activities |
|
-5.16
+24.01%
|
-6.79
+78.44%
|
-31.51
-66.98%
|
-18.87
|
| Net PPE Purchase And Sale |
|
-0.30
+59.92%
|
-0.76
+80.24%
|
-3.83
+64.74%
|
-10.85
|
| Purchase Of PPE |
|
-0.30
+59.92%
|
-0.76
+80.24%
|
-3.83
+64.74%
|
-10.85
|
| Capital Expenditure |
|
-5.16
+24.01%
|
-6.79
+47.93%
|
-13.05
+24.98%
|
-17.39
|
| Capital Expenditure Reported |
|
—
|
—
|
—
|
-17.39
|
| Net Business Purchase And Sale |
|
—
|
—
|
0.00
|
0.00
|
| Purchase Of Business |
|
—
|
—
|
0.00
|
0.00
|
| Net Intangibles Purchase And Sale |
|
-4.86
+19.51%
|
-6.04
+34.54%
|
-9.22
-40.89%
|
-6.55
|
| Purchase Of Intangibles |
|
-4.86
+19.51%
|
-6.04
+34.54%
|
-9.22
-40.89%
|
-6.55
|
| Net Other Investing Changes |
|
—
|
—
|
-18.46
-1151.39%
|
-1.48
|
| Financing Cash Flow |
|
-174.93
-10.47%
|
-158.34
-322.83%
|
-37.45
+81.75%
|
-205.24
|
| Cash Flow From Continuing Financing Activities |
|
-174.93
-10.47%
|
-158.34
-322.83%
|
-37.45
+81.75%
|
-205.24
|
| Net Issuance Payments Of Debt |
|
-173.35
-11.07%
|
-156.08
|
0.00
|
0.00
|
| Issuance Of Debt |
|
237.60
|
0.00
|
0.00
|
0.00
|
| Repayment Of Debt |
|
-410.95
-163.29%
|
-156.08
|
0.00
|
0.00
|
| Long Term Debt Issuance |
|
237.60
|
0.00
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
-410.95
-163.29%
|
-156.08
|
0.00
|
0.00
|
| Net Long Term Debt Issuance |
|
-173.35
-11.07%
|
-156.08
|
0.00
|
0.00
|
| Short Term Debt Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Short Term Debt Payments |
|
—
|
—
|
0.00
|
0.00
|
| Net Short Term Debt Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Net Common Stock Issuance |
|
0.00
|
0.00
+100.00%
|
-32.40
+79.75%
|
-160.00
|
| Common Stock Payments |
|
0.00
|
0.00
+100.00%
|
-32.40
+79.75%
|
-160.00
|
| Repurchase Of Capital Stock |
|
0.00
|
0.00
+100.00%
|
-32.40
+79.75%
|
-160.00
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
-1.57
+30.41%
|
-2.26
+55.29%
|
-5.05
+88.83%
|
-45.24
|
| Changes In Cash |
|
-142.60
+4.29%
|
-149.00
-215.65%
|
-47.20
+85.73%
|
-330.71
|
| Effect Of Exchange Rate Changes |
|
5.21
+231.63%
|
-3.96
-294.84%
|
2.03
+168.27%
|
-2.98
|
| Beginning Cash Position |
|
370.06
-29.25%
|
523.02
-7.95%
|
568.20
-37.00%
|
901.89
|
| End Cash Position |
|
232.67
-37.13%
|
370.06
-29.25%
|
523.02
-7.95%
|
568.20
|
| Free Cash Flow |
|
32.32
+246.06%
|
9.34
+7.34%
|
8.70
+107.02%
|
-123.99
|
| Interest Paid Supplemental Data |
|
14.44
+80.18%
|
8.01
-14.52%
|
9.38
-4.51%
|
9.82
|
| Income Tax Paid Supplemental Data |
|
—
|
2.80
+23.45%
|
2.27
|
—
|
| Change In Income Tax Payable |
|
—
|
—
|
1.28
+547.47%
|
0.20
|
| Change In Tax Payable |
|
—
|
—
|
1.28
+547.47%
|
0.20
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-22 View
- 42026-04-13 View
- 42026-04-13 View
- 42026-03-24 View
- 42026-03-24 View
- 42026-03-24 View
- 42026-03-24 View
- 42026-03-19 View
- 42026-03-19 View
- 42026-03-19 View
- 10-K2026-03-12 View
- 8-K2026-03-12 View
- 8-K2026-03-06 View
- 42025-11-17 View
- 10-Q2025-11-06 View
- 8-K2025-11-06 View
- 42025-11-04 View
- 8-K2025-11-03 View
- 42025-10-10 View
- 8-K2025-09-30 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|